Institute of Statistical Research and Training
Degree Name | Group/Major Subject | Board/Institute | Country | Passing Year |
---|---|---|---|---|
Ph.D. | Statistics | Queen Mary University of London | United Kingdom | 2015 |
Masters | Applied Statistics | University of Dhaka | Bangladesh | 2005 |
Bachelor | Applied Statistics | University of Dhaka | Bangladesh | 2003 |
Title | Organization | Location | From Date | To Date |
---|---|---|---|---|
Professor | University of Dhaka | Bangladesh | 15, Feb 2023 | Currently Working |
Associate Professor | University of Dhaka | Bangladesh | 15, Jun 2017 | 14-02-2023 |
Assistant Professor | University of Dhaka | Bangladesh | 25, Aug 2010 | 14-06-2017 |
Lecturer | University of Dhaka | Bangladesh | 27, Jan 2007 | 24-08-2010 |
Subject | Description | Research Interest (Goal, Target Indicator) |
---|---|---|
Statistical computing | ||
Clinical trials | ||
Optimal design | ||
Adaptive design |
Level of Study | Title | Supervisor | Co-Supervisor(s) | Name of Student(s) | Area of Research | Current Completion |
---|---|---|---|---|---|---|
Masters | Patient-specific dose finding in seamless phase I/II clinical trials | M. Iftakhar Alam | Shantonu Islam | Biostatistics | 2019 | |
Masters | A two-stage adaptive design for phase II clinical trials | M. Iftakhar Alam | Rezoanoor Rahman | Biostatistics | 2019 | |
Masters | Patient-specific dose finding in phase I clinical trials | M. Iftakhar Alam | Monirruzzaman Moni | Biostatistics | 2018 | |
Masters | Early stopping in seamless phase I/II clinical trials | M. Iftakhar Alam | Noor Muhammad Khan | Biostatistics | 2018 | |
Masters | D-optimal designs for dose finding in phase I clinical trials | M. Iftakhar Alam | Hasan Mahmud | Biostatistics | 2017 | |
Masters | Construction of windows for pharmacokinetic sampling | M. Iftakhar Alam | Nigar Sultana | Biostatistics | 2017 | |
Masters | Assessing the inter-patient variability in the area under the concentration curve | M. Iftakhar Alam | Syeda Asma Akter | Biostatistics | 2016 |
Subject | Project Name | Source of Fund | From Date | To Date | Collaboration |
---|---|---|---|---|---|
No project/research work is found |
SL | Invited Talk |
---|---|
No invited talk is found |
SL | Collaboration & Membership Name | Type | Membership Year | Expire Year |
---|---|---|---|---|
1 | International Society for Clinical Biostatistics, Denmark | Member | 2014- Till today | |
2 | International Statistical Institute, The Hague, Netherlands | Member | 2017-Till today |
Journal Article | |
---|---|
1 |
Rezoanoor Rahman and M. Iftakhar Alam : Stopping for efficacy in single-arm phase II clinical trials,
Journal of Applied Statistics Taylor and Francis , pp.1-20 , 2021
.
|
2 |
M. Iftakhar Alam and Nigar Sultana : Construction of windows for pharmacokinetic sampling,
Austrian Journal of Statistics , vol.50 Austrian Statistical Society , pp.23-37 , 2021
.
|
3 |
Noor M. Khan and M. I. Alam : Early stopping in seamless phase I/II clinical trials,
Pharmaceutical Statistics , vol.20 , no.2 Wiley , pp.390-412 , 2020
.
|
4 |
Alam, M. I, Coad, D.S. and Bogacka, B. : Combined criteria for dose optimisation in early phase clinical trials,
Statistics in Medicine , vol.38 , no.21 Wiley , pp.4172-4188 , 2019
.
|
5 |
Alam, M.I. and Sultana, Jafrin : Isotonic design for phase I clinical trials: can we improve further?,
Austrian Journal of Statistics , vol.48 Austrian Statistical Society , pp.34-44 , 2019
.
|
6 |
M. I. Alam : Assessing the inter-patient variability in the area under the concentration curve,
Journal of Statistical Research , vol.53 , no.1 , pp.27-44 , 2019
.
|
7 |
Moni, M.M. and Alam, M.I. : Patient-specific dose finding in phase I clinical trials,
Journal of Applied Statistics , vol.45 , no.14 Taylor and Francis , pp.2607-2618 , 2018
.
|
8 |
Alam, M.I. and Mansur, Mohaimen : A dynamic stopping rule for phase I clinical trials,
Biometrical Letters , vol.55 , no.1 Polish Biometric Society , pp.17-30 , 2018
.
|
9 |
Alam, M.I., Bogacka, B. and Coad, D.S. : Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials,
Computational Statistics and Data Analysis , vol.117 , no.2017 Elsevier , pp.183-202 , 2017
.
|
10 |
Alam, M.I. and Hossain, M.I. : On performance of the 3+3 design and its modified versions for dose finding in phase I clinical trials,
Journal of Data Science , vol.15 , no.1 , pp.115-128 , 2017
.
|
11 |
Alam, M.I. : A comparison between the continual reassessment method and D-optimum design for dose finding in phase I clinical trials,
Biometrical Letters , vol.53 , no.2 Polish Biometric Society , pp.69-82 , 2016
.
|
12 |
Rezoanoor Rahman and M. Iftakhar Alam : Stopping for efficacy in single-arm phase II clinical trials. Journal of Applied Statistics, 1-20.,
Journal of Applied Statistics Taylor and Francis , pp.1-20 , 2021
.
|
13 |
M. Iftakhar Alam, Mohaimen Mansur and Prianka Barman : Early childhood development in Bangladesh and its socio-demographic determinants of importance,
Early Child Development and Care Taylor and Francis , pp.1-20 , 2021
.
|
14 |
Hasan Mahmud Sujan and M. Iftakhar Alam : D-optimal designs for dose finding in phase I clinical trials,
Journal of Statistical Research , vol.55 , no.2 , pp.313-334 , 2022
.
|
15 |
M. Iftakhar Alam and Nigar Sultana : Attitudes of women toward domestic violence: what matters the most?,
Violence and Gender , vol.9 , no.2 Mary Ann Liebert , pp.87-95 , 2022
.
|
Award Type | Title | Year | Country | Description |
---|---|---|---|---|
International | Conference Award for Scientists | 2016 | United Kingdom | Received from the International Society for Clinical Biostatistics (ISCB). I was one of the three early-career researchers from the developing nations to receive this award. |
International | Student Conference Award | 2013 | Germany | Received from the International Society for Clinical Biostatistics (ISCB). I was one of the three research students worldwide to receive this award. |
National | Fazlul Huq Hall Provost Award | 2004 | Bangladesh | Received for securing the first position in the B.Sc. (Honours) final examination. |